Mark S Shearman Insider Trading
Get free email notifications about insider trading for Mark S Shearman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark S Shearman. Mark S Shearman is a Chief Scientific Officer in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and a EVP, Chief Scientific Officer in Editas Medicine, Inc. ($EDIT).
Address: C/O APPLIED GENETIC TECHNOLOGIES CORP. 11801 RESEARCH DRIVE, SUITE D ALACHUA 32615 FL
Companies in which Mark S Shearman is an Insider
APPLIED GENETIC TECHNOLOGIES CORP
Trading Symbol: AGTCIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark S Shearman: Chief Scientific Officer
Holdings: 33,277 shares
Current Value: $214,637
Latest Transaction: Aug 18 2020
$AGTC Market Capitalization: $115.53M
$AGTC Previous Close: $6.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Trading Symbol: EDITIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark S Shearman: EVP, Chief Scientific Officer
Holdings: 32,701 shares
Current Value: $606,931
Latest Transaction: Jun 16 2021
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark S Shearman
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | EDIT | Editas Medicine, I ... | Shearman Mark S | EVP, Chief Scientif ... | Option Exercise | A | 38.53 | 52,718 | 2,031,225 | 52,718 | |
Jun 16 2021 | EDIT | Editas Medicine, I ... | Shearman Mark S | EVP, Chief Scientif ... | Grant | A | 0.00 | 32,701 | 0 | 32,701 | 0 to 32.7 K |
Aug 18 2020 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Payment of Exercise | F | 5.77 | 5,723 | 33,022 | 33,277 | 39 K to 33.3 K (-14.67 %) |
Aug 07 2020 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 5.50 | 50,000 | 275,000 | 50,000 | |
Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 3.00 | 52,000 | 156,000 | 52,000 | |
Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Grant | A | 0.00 | 39,000 | 0 | 39,000 | 0 to 39 K |
Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Sell | S | 3.35 | 3,000 | 10,053 | 0 | 3 K to 0 (-100.00 %) |